XML 251 R50.htm IDEA: XBRL DOCUMENT v3.22.0.1
Capital Structure, Financial Risk and Related Items - Warrant Activity (Details) - kr / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Balance at beginning of period 988,468 1,413,624 1,423,210
Granted 175,984 118,228 307,219
Exercised (172,708) (471,246) (299,431)
Expired     (2,000)
Cancelled (23,293) (72,138) (15,374)
Balance at end of period 968,451 988,468 1,413,624
Exercisable at year end 411,724 346,716 638,248
Exercisable warrants in the money at year end 411,724 346,716 627,061
Weighted average exercise price of warrants at beginning kr 1,247.22 kr 862.03 kr 592.14
Weighted average exercise price of warrants granted 2,282.35 2,009.79 1,483.58
Weighted average exercise price of warrants exercised 780.48 296.77 212.23
Weighted average exercise price of warrants expired     129.75
Weighted average exercise price of warrants cancelled 1,956.91 1,157.54 1,049.34
Weighted average exercise price of warrants at ending 1,501.49 1,247.22 862.03
Weighted Average Exercise Price Of Warrants Exercisable 1,058.41 935.60 407.89
Weighted Average Exercise Price Of Warrants Exercisable In Money 1,058.41 kr 935.60 kr 385.84
Percentage of share capital attributed to exercise of warrants   1.00% 2.00%
Weighted average exercise price of fair market value kr 2,439.80 kr 2,035.29 kr 1,267.92
Board of Directors      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Balance at beginning of period 11,941 62,334 74,478
Granted 1,217   3,925
Exercised (2,500) (24,438) (15,750)
Transfers   (25,955) (319)
Balance at end of period 10,658 11,941 62,334
Exercisable at year end 6,594 4,192 50,227
Exercisable warrants in the money at year end 6,594 4,192 50,227
Executive Management      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Balance at beginning of period 140,815 347,801 480,201
Granted 1,287 7,771  
Exercised (7,250)   (132,400)
Cancelled   (28,424)  
Transfers 24,782 (186,333)  
Balance at end of period 159,634 140,815 347,801
Exercisable at year end 135,723 83,426 230,233
Exercisable warrants in the money at year end 135,723 83,426 227,733
Employees      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Balance at beginning of period 732,577 858,973 706,088
Granted 167,080 110,041 303,066
Exercised (105,726) (122,015) (56,237)
Cancelled (477) (589)  
Transfers (54,454) (113,833) (93,944)
Balance at end of period 739,000 732,577 858,973
Exercisable at year end 219,386 166,402 225,855
Exercisable warrants in the money at year end 219,386 166,402 219,403
Former Member Of Board Of Directors and Employees      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Balance at beginning of period 103,135 144,516 162,443
Granted 6,400 416 228
Exercised (57,232) (324,793) (95,044)
Expired     (2,000)
Cancelled (22,816) (43,125) (15,374)
Transfers 29,672 326,121 94,263
Balance at end of period 59,159 103,135 144,516
Exercisable at year end 50,021 92,696 131,933
Exercisable warrants in the money at year end 50,021 92,696 129,698
Warrants Granted from August 2004 until April 2012      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Percentage of share capital attributed to exercise of warrants 25.00%    
Warrants Granted from April 2012 until February 2021      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Warrant vesting period 4 years    
Warrants Granted from March 2017 until February 2021      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Warrant vesting period 3 years